Clinical efficacy of fluvastatin in thelong-term treatment of familial hypercholesterolemia

Junii Koizumi(Kanazawa University), Ryoyu Takeda(Kanazawa University), Susurnu Miyamoto(Kanazawa University), Masayuki Ohta, Kouii Kalinami(Kanazawa University), Tatsuo Haraki(Kanazawa University), Akihiro Inazu(Kanazawa University), Hiroshi Mabuchi(Kanazawa University), Yoshihide Uno(Ishikawa Prefectural Central Hospital), Mitsuaki TAKEDA(Kanazawa University), K. Yagi(Kanazawa University), Tadayoshi Takegoshi(Uwajima City Hospital), Kosei Ueda(Ueda Womens Junior College)
The American Journal of Cardiology
July 1, 1995
10.1016/s0002-9149(05)80016-5
Cited by 21

Related Papers

Increased High-Density Lipoprotein Levels Caused by a Common Cholesteryl-Ester Transfer Protein Gene Mutation
|New England Journal of Medicine|1990|865
Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins
|Nature|1989|465
T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity
|Clinical Science|2003|313
T‐peak to T‐end interval may be a better predictor of high‐risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin i mutation than qt dispersion
|Clinical Cardiology|2002|267
Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.
|Circulation|1981|250